Not provided
Not provided
Not provided
Not provided
Not provided
Sponsor financial decision stemming from low recruitment
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Palm Beach CRO | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
A two-year + 3 Mo. observational study to track compliance and outcomes in adult patients prescribed compounded pharmaceutical creams for the treatment of pain. The project is designed to accumulate tracking information from both patients and physicians over the course of therapy as a supplement to the ordinary care that the patients will normally receive. We seek to discover aspects of successful and unsuccessful treatment using topical pain creams. This information will be analyzed and reports prepared of observations and emergent findings. These reports will be sent during the study every 1 or 2 months to patients, physicians and pharmacists who are participating in the Study. A final compilation of findings and observations will be circulated to participating patients, physicians and pharmacists.
Description Of Data Relevant to Objectives:
The primary objective of this study is to document clinical experience. Specifically, the study will collect:
Registry Procedures:
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Prescribed Compounded Pain Cream | The study is limited to patients who have been prescribed treatment with a topical compounded pain cream as a component of their ordinary care by a qualified physician. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Compounded Pain Cream | Other | All patients will have been prescribed a topical pain cream prepared by a qualified compounding pharmacy |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change in patient reported pain levels following treatment | Across active subjects who have a Baseline pain level AND a followup pain level as of 1 year following first patient enrolled (FPI). Applies to the intended use of the pain cream as established by the diagnosis and area to be treated. | One year following first patient enrolled |
| Measure | Description | Time Frame |
|---|---|---|
| Patient global impression of benefit | Assessed by a structured VAS for completion at followup and final visits. Will be assessed for all patients who have reported on the first followup visit. Mean and distribution will be reported. | One year after first patient enrolled |
| Measure | Description | Time Frame |
|---|---|---|
| Frequency that patients do NOT use the pain cream as instructed | Both incidence (a count and percentage) and 5 most common reasons given by patients for not following the prescription will be reported. The information is proactively captured at followup visits. Baseline establishes prescribed use. Followup items probe for uses inconsistent with prescription. The population will include all subjects as of 1 year following FPI who have reported a followup visit. |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Males and females at least 18 years of age residing in the United States
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Stephen A. Raymond, PhD | Research and Marketing Consultants | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Lido Chen | Laguna Hills | California | 92653 | United States | ||
| Adolphus Anekwe |
Not provided
| ID | Term |
|---|---|
| D059350 | Chronic Pain |
| D059787 | Acute Pain |
| D000377 | Agnosia |
| ID | Term |
|---|---|
| D010146 | Pain |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
Not provided
Not provided
Not provided
| One year following first patient enrolled (FPI). |
| Gary |
| Indiana |
| 46409 |
| United States |
| D010468 | Perceptual Disorders |
| D019954 | Neurobehavioral Manifestations |
| D009422 | Nervous System Diseases |